Sakai Satoshi | Cardiovascular Division Institute Of Clinical Medicine Graduate School Of Comprehensive Human Scienc

スポンサーリンク

概要

関連著者

もっと見る

著作論文

P349 Plasma Nitrate Concentrations in Young Patients with Congenital Heart Diseases
P266 LACK OF MODULATION OF VASCULAR TONUS BY ENDOTHELIN-1 DURING EXERCISE IN PATIENTS WITH HEART FAILURE
PE-036 Contrast Medium-Induced Renal Damage is Tightly Associated with Endothelial Injury in Patients(PE006,Kidney/Renal Circulation/CKD 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
DPJ-048 Can Intravascular Optical Cohenrence Tomography Detect Plaque Erosion? : Some New Findings in Rabbit Models(DPJ08,Intravascular Imagings (I),Digital Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
DPJ-021 Commercially Available Serum N-terminal proBNP Level Accurately Differentiates Presence of Cardiac Morphological and Hemodynamic Abnormalities Compared with Brain Natriuretic Peptide(DPJ04,Heart Failure (Diagnosis) (M),Digital Poster Session (Japa
OJ-045 Altered Characteristics of Endothelial Cells in Patients with Pulmonary Arterial Hypertension Estimated by Endothelial Cell-Derived Microparticles(OJ08,Pulmonary Circulation (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The
OE-336 Optical Coherence Tomographic Findings of Macrophage Accumulation in Atherosclerotic Lesions(OE57,Intravascular Imagings (I),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PE-369 The Histological Findings of Vascular Response to Drug Eluting Stents(PE062,Atherosclerosis (Clinical/Treatment) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PE-233 Validation of Left Ventricular Volumetric Data by 3 Dimensional Speckle Tracking Imaging with Cardiac Magnetic Resonance Imaging(PE039,Echo/Doppler (Others) (I),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
Poor Survival of Cardiomyopathic Hamsters with CHF Is Greatly Improved by Combined Treatment with Endothelin (ET)-A Receptor Antagonist and ACE Inhibitor
IS004 Cloning of hamster prepro-endothelin-1 cDNA and the pathophysiological roles of myocardial endothelin-1 in the failing heart due to cardiomyopathy in hamsters
IS097 Chronic treatment with endothelin inhibitor greatly improves survival in hamsters with heart failure due to dilated cardiomyopathy : increased expression of endothelin-1 in failing heart
In vivo Direct Nitric Oxide (NO) Measurement in the Rat Abdominal Aorta Using Novel Clinically Practicable NO Sensor-tipped Catheter(Atherosclerosis, Basic 6 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Hypotensive Effects of an Angiotensin II Type 1 Receptor Antagonist Differ between Exercised and Sedentary Rats Aged from 4 to 19 Weeks
P680 PHYSICAL EXERCISE PROMOTES THE INHIBITORY EFFECT OF THE ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST TCV-116 ON SYSTOLIC BLOOD PRESSURE IN NORMAL RATS.
0107 Enhanced Endothelin Pathway Is Involved in the Development of Cardiac Hypertrophy in the Mouse Transgenically Activated Renin-Angiotensin System
1068 Endothelin-1 Level in the hypertrophied heart of Tsukuba Hypertensive Mice
PE-332 Left Atrial Volumes Assessed by Echocardiography Compared to Magnetic Resonance Imaging(Echo/Doppler-12, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
IS078 Expression of endothelin (ET)-1, ET_A, receptor, ET_B receptor, ET-converting enzyme and cellular distribution of ET-1 staining in the failing heart due to myocardial infarction in rats
P784 DOES MYOCARDIAL ENDOTHELIN-1 PARTICIPATE IN THE MODULATION OF CARDIAC FUNCTION DURING EXERCISE?
P627 EXPRESSION OF ENDOTHELIN RECEPTOR SUBTYPBS AND ANGIOTENSIN RECEPTOR SUBTYPES IN THE HEART OF RATS WITH CHRONIC HEART FAILURE
P517 Increased Plasma Nitrate and Endothelin-1 Levels in Rats with Monocrotaline-Induced Pulmonary Hypertension
OJ-065 Inhibitory Effect of Fluvastatin on Cardiac hypertrophy is Partly Attributed to Interference of JNK and Pin-1 Activation(Cardiovascular pharmacology, basic/clinical(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japane
PJ-636 Regulation of RNA Polymerase II (Pol II)-Driven Gene Expression and Cardiomyocyte Size by C-Terminal Domain Phosphatase of Pol II(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of
PJ-618 The PPAR-α Activator Fenofibrate Inhibits Myocardial Fibrosis with Improving Diastolic Function in DOCA-salt Hypertensive Rats, Partly via Suppressing Endothelin-1 Expression(Cardiac Hypertrophy, Basic and Clinical 2 (M) : PJ104)(Poster Session (Ja
Decreases in Exercise Capacity, Myocardial Energy Metabolism, and Survival in Rats with CHF Are Greatly Improved by Endothelin-A Receptor Antagonist
0894 EXPRESSION OF ENDOTHELIN RECEPTOR MESSENGER RNA IN THE CONGESTIVE LUNG IN RATS WITH CHRONIC HEART FAILURE
0884 ENDOTHELIN CONVERTING ENZYME AND ANGIOTENSIN CONVERTING ENZYME IN THE HEART OF RATS WITH CHRONIC HEART FAILURE
0804 EXPRESSION OF ENDOTHELIN-1 mRNA IN THE HEART OF PATHOLOGICAL HYPERTROPHY OR PHYSIOLOGICAL HYPERTROPHY
0234 Treatment with an Endothelin Receptor Antagonist Ameliorates Chronic Heart Failure in Rats and Inhibits the Alteration of the Expression of Cardiac Genes
Cardiac Hypertrophy by Hypertension and Exercise Training Exhibits Different Gene Expression of Enzymes in Energy Metabolism
-0705- Endothelin-1 and cardiac hypertrophy due to pressure or volume overload in rats(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
-0657- Effects of an endothelin-A receptor antagonist on the pulmonary hypertension caused by congestive heart failure in Rats(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
Fenofibrate, one of peroxisome proliferator-activated receptor α (PPAR-α) activators, inhibits cardiac fibrosis by depression of both fibroblast proliferation and collagenesis
Stimulation of Peroxisome Proliferator-Activated Receptor-α (PPAR-α) Attenuates Endothelin-1-Induced Cardiac Hypertrophy Partly via Inhibition of c-Jun NH_2 Terminal Kinase (JNK) Pathway
Prediction of Chronic Renal Insufficiency After Coronary Angiography by an Early Increase in Oxidative Stress and Decrease in Glomerular Filtration Rate
Combination of endothelin-A (ET_A) receptor inhibitor and prostacyclin (PGI_2) analogue is preferable to each drug alone for pulmonary hypertension (PH)
Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis
0381 Study of the Expression of Family Proteins of MSP23 Protein in the Hypertrophied Rat Heart
A PPAR-α Activator Inhibits Cardiac Fibrosis by Inhibiting of Fibroblast Proliferation and Collagenesis in Cultured Fibroblasts and DOCA-Salt Hypertensive Rats
1123 Treatment with an Endothelin Receptor Antagonist Ameliorates Chronic Heart Failure in Rats
-P402- Study of endothelin-1-like immunoreactivity in the lung of rats with pulmonary hypertension caused by monocrotaline(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
(E61013) Physiological Hypertrophy and Pathological Hypertrophy Induce Different Molecular Phenotypes in the Rat Heart

もっと見る

スポンサーリンク